Increase in SCr level: ≥ two‐fold from baseline level SCr level (mg/dL) · patients in treatment with amphotericin B
Amphotericin B deoxycholate probably leads to lower increase in SCr level: ≥ two‐fold from baseline level SCr level… compared with liposomal amphotericin B: effects on kidney function (moderate certainty).
1 finding from 1 review
Adverse effects: postoperative lens rotation requiring second procedure to re‐align toric IOL · people with astigmatism who are having cataract surgery (phacoemulsification)
1 finding from 1 review
Serum UA · people with CKD
1 finding from 1 review
Maternal and perinatal outcome (Kirkpatrick level 4: patient outcome)
1 finding from 1 review
Performance of obstetric team in practice (Kirkpatrick level 3: behavioural change)
1 finding from 1 review
Maternal death
It is very uncertain whether simulation‐based obstetric team training changes maternal mortality (Kirkpatrick level 4: patient outcome) compared with no training (very low certainty).
1 finding from 1 review
Neonatal mortality
Simulation‐based obstetric team training showed no clear difference in neonatal mortality (Kirkpatrick level 4: patient outcome) compared with no training (low certainty).
1 finding from 1 review
Low Apgar score
Simulation‐based obstetric team training showed no clear difference in low Apgar score (Kirkpatrick level 4: patient outcome) compared with no training (low certainty).
1 finding from 1 review
Trauma due to shoulder dystocia (Kirkpatrick level 4: patient outcome)
Simulation‐based obstetric team training showed no clear difference in trauma due to shoulder dystocia (Kirkpatrick level 4: patient outcome) compared with no training (moderate certainty).
1 finding from 1 review
Cesarean delivery (Kirkpatrick level 4: patient outcome)
Simulation‐based obstetric team training probably leads to lower cesarean delivery (Kirkpatrick level 4: patient outcome) compared with no training (moderate certainty).
1 finding from 1 review
Quadriceps muscle strength Handheld or fixed dynamometry · adults with advanced disease for muscle weakness
1 finding from 1 review
Days to regain birth weight · feed interruption while monitoring gastric residual
1 finding from 1 review
Number of infants with feed interruption episodes (lasting ≥ 12 hours) · feed interruption while monitoring gastric residual
It is very uncertain whether summary of findings table ‐ Quality and volume of gastric residual changes number of infants with feed interruption episodes (lasting ≥ 12 hours) compared with quality of gastric residual alone (very low certainty).
1 finding from 1 review
Duration (days) of parenteral nutrition · feed interruption while monitoring gastric residual
1 finding from 1 review
Risk of invasive Infection · feed interruption while monitoring gastric residual
Summary of findings table ‐ Quality and volume of gastric residual showed no clear difference in risk of invasive Infection compared with quality of gastric residual alone (low certainty).
1 finding from 1 review
Mortality before hospital discharge · feed interruption while monitoring gastric residual
Summary of findings table ‐ Quality and volume of gastric residual showed no clear difference in all‐cause mortality before hospital discharge compared with quality of gastric residual alone (low certainty).
1 finding from 1 review
Risk of necrotising enterocolitis stage ≥ 2 · feed interruption while monitoring gastric residual
Summary of findings table ‐ Quality and volume of gastric residual showed no clear difference in risk of necrotising enterocolitis stage ≥ 2 compared with quality of gastric residual alone (low certainty).
1 finding from 1 review
Time to achieve full enteral feeding (days) · feed interruption while monitoring gastric residual
1 finding from 1 review
Healthcare utilisation · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health outcomes · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found